Tesamorelin TSM2 2mg*10vials

Tesamorelin TSM2 (2mg x 10 vials) is a high-purity, modified synthetic growth hormone-releasing hormone (GHRH) analog research peptide, and a foundational entry-level product in the TSM series. As a structurally optimized derivative of Sermorelin, Tesamorelin exhibits higher molecular stability and targeted lipolysis specificity compared to traditional GHRH peptides. Thanks to its unique amino acid modification design, it effectively resists enzymatic degradation, achieving mild and sustained GH/IGF-1 axis activation, and possesses superior ability to target abdominal and visceral fat metabolism, distinguishing it from ordinary growth hormone secretagogues. This 2mg low-precision formulation of Tesamorelin is specifically developed for basic research on visceral fat metabolism mechanisms, mild endocrine remodeling, long-term low-dose body composition optimization, and baseline biosafety validation experiments. It is a core research material for preclinical studies of lipid metabolism disorders, hepatic lipid accumulation, and age-related metabolic decline.

Product Functions and Research Value

Laboratory studies have shown that Tesamorelin TSM2 can stably activate the endogenous GH/IGF-1 signaling pathway according to physiological rhythms, triggering a gentle and orderly pulsed secretion of growth hormone, avoiding drastic fluctuations in hormone levels or endocrine feedback inhibition. Unlike conventional Sermorelin, which focuses on overall anabolism, Tesamorelin has significant targeted visceral fat degradation and abdominal fat remodeling properties. It can effectively upregulate the expression of genes related to mitochondrial oxidative phosphorylation, promote deep fat metabolism, inhibit hepatic lipid deposition, and improve mild fatty liver metabolic disorders. Simultaneously, it retains basic physiological functions such as maintaining lean tissue, promoting collagen synthesis, and improving chronic endocrine balance. The 2mg low-dose TSM2 version has an ultra-gentle intervention effect, excellent model tolerability, and no risk of hormone desensitization. It is ideal for long-term chronic metabolic baseline studies, exploration of low-dose lipid metabolism mechanisms, and validation of safety thresholds, providing highly stable and reproducible baseline data for targeted lipid regulation and gentle anti-aging endocrine studies.

Core Product Advantages

1. TSM2 Basic Professional Baseline Version: The entry-level version of the TSM series, based on an optimized molecular structure of traditional GHRH peptides. It retains complete physiological endocrine activation properties while significantly enhancing the specificity of lipid metabolism targeting, filling a gap in basic targeted lipolysis research.

2. Unique Visceral Fat Targeted Regulation: Possesses advantages in abdominal and visceral fat remodeling not found in ordinary GHRH peptides. It specifically acts on deep adipose tissue and liver lipid metabolism pathways, effectively improving fat accumulation and abnormal lipid metabolism.

3. Enhanced Molecular Stability and Gentle Sustained Efficacy: Structural modification improves anti-degradation capacity, achieving a longer in vivo retention time and a gentler sustained activation effect compared to unmodified GHRH. No hormone spikes ensure long-term stable metabolic regulation.

4. 2mg Low-Dose, High-Safety Specification: Professional entry-level low-concentration design avoids physiological stress. This product targets receptor desensitization and metabolic burden caused by high-dose interventions, making it ideal for long-term chronic experiments and baseline safety studies with controllable risks. 5. High-purity, pharmaceutical-grade quality: Utilizing aseptic vacuum freeze-drying technology to lock in all peptide activity. Each batch undergoes rigorous HPLC purity testing and comes with a complete official Certificate of Account (COA). The 10-vial aseptic integrated packaging is suitable for routine laboratory basic research, university metabolic mechanism projects, and large-scale wholesale purchases.

Tesamorelin TSM2 2mg*10-vial pack is a high-purity modified synthetic growth hormone-releasing hormone (GHRH) analog research peptide, a basic entry-level product in the TSM series. As a structurally optimized derivative of Sermorelin, Tesamorelin exhibits stronger molecular stability and higher targeting specificity, offering a **unique advantage** in visceral fat targeting metabolism compared to traditional GHRH peptides. Thanks to its proprietary amino acid modification structure, Tesamorelin effectively resists enzymatic degradation, thereby achieving gentle and sustained activation of the GH/IGF-1 endocrine axis. It precisely targets deep adipose tissue and liver lipid metabolism pathways, a core characteristic not possessed by ordinary growth hormone peptides.